非酒精性脂肪性肝病肠道菌群的研究进展

刘嘉琪; 周少明

doi:10.3969/j.issn.1001-5256.2017.12.045

非酒精性脂肪性肝病肠道菌群的研究进展

DOI: 10.3969/j.issn.1001-5256.2017.12.045

深圳市儿童医院

基金项目:

圳市科技创新委员会2016年基础研究项目(JCYJ20160429174706491)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 1315
- HTML全文浏览量: 28
- PDF下载量: 376
- 被引次数: 0
出版历程
- 收稿日期: 2017-09-07
- 出版日期: 2017-12-20

Research advances in intestinal flora in nonalcoholic fatty liver disease

Shenzhen Children's Hospital

Research funding:

摘要

摘要: 非酒精性脂肪性肝病发病率不断升高且起病年龄渐趋低龄化,其发病机制至今尚未明确。在众多致病因素中,肠道菌群的改变与非酒精性脂肪性肝病的发病及进展密切相关。归纳了肠道菌群在非酒精性脂肪性肝病发生及发展中的作用机制,以及通过调节肠道菌群治疗非酒精性脂肪性肝病的方式。可见通过调节肠道菌群,恢复肠道微生态平衡,对延缓乃至阻止非酒精性脂肪性肝病的进展可能有重要的作用,成为预防及治疗该病的新方法。
- 非酒精性脂肪性肝病 /
- 肠杆菌科 /
- 综述
Abstract: Nonalcoholic fatty liver disease ( NAFLD) is a common chronic liver disease in our country, and its incidence rate is gradually increasing and the age of onset is becoming younger. The pathogenesis of NAFLD remains unclear. Among a variety of pathogenic factors, the change in intestinal flora is closely associated with the development and progression of NAFLD. This article summarizes the mechanism of action of intestinal flora in the development and progression of NAFLD and the treatment of NAFLD by regulating intestinal flora. It is pointed out that regulation of intestinal flora and restoration of intestinal microecological balance may play an important role in delaying or inhibiting the progression of NAFLD and may become a new method for the prevention and treatment of this disease.
- nonalcoholic fatty liver disease /
- enterobacteriaceae /
- review

HTML全文

参考文献(24)

[1]LI YY, GASTROENTEROLOGY DO.Gut microbiota disturbance and non-alcoholic fatty liver disease[J].World Chin J Dig, 2015, 23 (15) :2355-2362.

[2]LOZUPONE CA, STOMBAUGH JI, GORDON JI, et al.Diversity, stability and resilience of the human gut microbiota[J].Nature, 2012, 489 (7415) :220-230.

[3]ROBERFROID M, GIBSON GR, HOYLES L, et al.Prebiotic effects:Metabolic and health benefits[J].Br J Nutr, 2010, 104 (Suppl 2) :s1-s63.

[4]LIN R.Role of gut-liver axis in the development and progression of chronic liver diseases[J].Curr Physician, 2015, 21 (9) :9-11. (in Chinese) 林睿.肠-肝轴在慢性肝病发生发展中的作用[J].当代医学, 2015, 21 (9) :9-11.

[5]CHEN M, KONG Y, WANG J, et al.Correlation between intestinal flora and nonalcoholic fattyliver disease:a review on research progress[J].Chin J Microecol, 2015, 27 (8) :989-993.

[6]FEROLLA SM, ARMILIATO GN, COUTO CA, et al.Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease[J].World J Hepatol, 2015, 7 (3) :559-565.

[7]LAU E, CARVALHO D, FREITAS P.Gut Microbiota:Association with NAFLD and Metabolic Disturbances[J].Biomed Res Int., 2015, 2015:979515.

[8]WANG Y, XI HY, LI LH, et al.Intestinal bacterial translocation and bloodstream infection[J].Mil Med J Southeast China, 2014, 16 (5) :514-516. (in Chinese) 王颖, 奚海燕, 李玲慧, 等.肠道细菌移位与血流感染[J].东南国防医药, 2014, 16 (5) :514-516.

[9]LI Y, WU J.Advances in research of intestinal bacterial translocation[J].World Chin J Dig, 2015, 23 (6) :938-943.

[10]YANG LH, CAI J, CHEN DF.Alteration and significance of intestinal flora in patients with NASH[J].J Clin Hepatol, 2012, 28 (2) :124-126. (in Chinese) 杨林辉, 蔡俊, 陈东风.非酒精性脂肪性肝炎患者肠道菌群的变化及意义[J].临床肝胆病杂志, 2012, 28 (2) :124-126.

[11]GUAN Y, CAO WJ, ZHANG ZY.Relationship between gut microbiota and non-alcoholic fatty liver disease[J].World Chin J Dig, 2015, 23 (36) :5797-5802.

[12]KOUICHI M, HIROHIDE O.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease[J].World J Gastroenterol, 2014, 20 (23) :7381-7391.

[13]FRASINARIU OE, CECCARELLI S, ALISI A, et al.Gut-liver axis and fibrosis in nonalcoholic fatty liver disease:an input for novel therapies[J].Dig Liver Dis, 2013, 45 (7) :543-551.

[14]MARKEL TA, CRISOSTOMO PR, WAIRIUKO GM, et al.Cytokines in necrotizing enterorcolitis[J].Shock, 2006, 25 (4) :329-337.

[15]HUANG R, OU XL.Research advances in the pathogenesis of intestinal mucosal barrier function impairment and its prevention and treatment[J].Modern Med, 2015, 43 (5) :659-662. (in Chinese) 黄蓉, 欧希龙.肠道黏膜屏障功能损伤机制及其防治的研究进展[J].现代医学, 2015, 43 (5) :659-662.

[16]WANG XT, HAN T.A review of relation ship between gutmicroecology and liver diseases[J].J Clin Hepatol, 2015, 31 (4) :642-644. (in Chinese) 王晓彤, 韩涛.肠道微生态与肝病的关系[J].临床肝胆病杂志, 2015, 31 (4) :642-644.

[17]ABU-SHANAB A, QUIGLEY EM.The role of the gut microbiota in nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol, 2010, 7 (12) :691-701.

[18]RAANAN S, RUURD VE, JAN K, et al.Significance of intestinal flora and nutrition in development and health in future[M].Australia Wiley Asia Pty Ltd, 2015:56-67.

[19]WAN X, WANG XY, LI L.Research progression of short chain fatty acid[J].Chin J Gastrointest Surg, 2015, 18 (9) :958-960.

[20]WANG XW, GAO PF, YAO GQ, et al.Research progress on relationship between NAFLD and gut microbiota/probiotics[J].Modern Prevent Med, 2015, 42 (12) :2153-2155.

[21]FAN JG.Regulate intestinal microecological balance-new targets for the prevention and treatment of steatohepatitis[J].Mod Med Health, 2007, 23 (3) :317-318. (in Chinese) 范建高.调理肠道微生态平衡-脂肪性肝炎防治的新靶点[J].现代医药卫生, 2007, 23 (3) :317-318.

[22]YAN HM, XIA MF, WANG Y, et al.Efficacy of berberine in patients with non-alcoholic fatty liver disease[J].PLo S One, 2015, 10 (8) :e0134172.

[23]CHIVA M, SORLANO G, ROCHAT I, et al.Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis[J].J Hepatol, 2002, 37 (4) :456-462.

[24]BIANCHI ME.DAMPs, PAMPs and alarmins:all we need to know about danger[J].J Leukoe Biol, 2007, 81 (1) :1-5.

施引文献

资源附件(0)

访问统计